文献速递血液净化与透析

血液透析患者衰弱的相关因素及其变化轨迹

Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-06-02

研究纳入762例血液透析患者,在基线、12和24个月评估衰弱(0-5个组分),采用有序广义估计方程分析。衰弱评分年均变化0.2分(95%CI 0.1-0.3),西班牙裔和糖尿病与更高衰弱评分相关,白蛋白更高与更低评分相关。炎症标志物和住院与衰弱恶化独立相关。

要点

  • 血液透析患者衰弱评分年际变化大,改善与恶化人数相近。
  • 西班牙裔、糖尿病与更高衰弱评分相关,高白蛋白与更低评分相关。
  • IL-6升高和住院与衰弱恶化独立相关,nPCR无独立关联。

核心结论

  • 血液透析患者衰弱评分年际变异大,改善与恶化人数大致相等。
  • 炎症标志物和住院与衰弱恶化独立相关。

研究设计与样本

  • A Cohort to Investigate the Value of Exercise/Analyses Designed to Investigate the Paradox of Obesity and Survival in ESRD队列研究,纳入762例血液透析患者,基线、12和24个月评估衰弱。
  • 采用有序广义估计方程分析衰弱(0-5个组分)和随访期间死亡。

主要发现

  • 基线平均衰弱评分为1.9,各次评估分布相似,但多数患者评分有变化,总体年均变化0.2分(95%CI 0.1-0.3)。
  • 西班牙裔年均高0.6分(95%CI 0.0-1.1),糖尿病年均高0.7分(95%CI 0.3-1.0),白蛋白每升高1 g/dl年均低1.1分(95%CI -1.5至-0.7)。
  • 白蛋白随时间每升高1 g/dl,衰弱评分降低0.4分(95%CI -0.80至-0.05)。
  • 第二模型显示IL-6升高和住院与任一时刻更差衰弱及衰弱恶化独立相关,nPCR无独立关联。

临床怎么用

  • 临床应关注血液透析患者衰弱评分的动态变化,定期评估。
  • 对西班牙裔、糖尿病患者及低白蛋白者加强衰弱监测。
  • 炎症和住院后康复可能是改善衰弱轨迹的干预靶点。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Frailty is common among patients on hemodialysis and associated with adverse outcomes. However, little is known about changes in frailty over time and the factors associated with those changes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To address these questions, we examined 762 participants in the A Cohort to Investigate the Value of Exercise/Analyses Designed to Investigate the Paradox of Obesity and Survival in ESRD cohort study, among whom frailty was assessed at baseline and 12 and 24 months. We used ordinal generalized estimating equations analyses and modeled frailty (on a scale from zero to five possible components) and death during follow-up. RESULTS: The mean frailty score at baseline was 1.9, and the distribution of frailty scores was similar at each evaluation. However, most participants' scores changed, with patients improving almost as often as worsening (overall change, 0.2 points per year; 95% confidence interval, 0.1 to 0.3). Hispanic ethnicity (0.6 points per year; 95% confidence interval, 0.0 to 1.1) and diabetes (0.7 points per year; 95% confidence interval, 0.3 to 1.0) were associated with higher frailty scores and higher serum albumin concentration with lower frailty scores (-1.1 points per g/dl; 95% confidence interval, -1.5 to -0.7). In addition, patients whose serum albumin increased over time were less likely to become frail, with each 1-g/dl increase in albumin associated with a 0.4-point reduction in frailty score (95% confidence interval, -0.80 to -0.05). To examine the underpinnings of the association between serum albumin and frailty, we included serum IL-6, normalized protein catabolic rate, and patient self-report of hospitalization within the last year in a second model. Higher IL-6 and hospitalization were statistically significantly associated with worse frailty at any point and worsening frailty over time, whereas normalized protein catabolic rate was not independently associated with frailty. CONCLUSIONS: There was substantial year to year variability in frailty scores, with approximately equal numbers of patients improving and worsening. Markers of inflammation and hospitalization were independently associated with worsening frailty. Studies should examine whether interventions to address inflammation or posthospitalization rehabilitation can improve the trajectory of frailty.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Johansen KL, Dalrymple LS, Delgado C, et al. Factors Associated with Frailty and Its Trajectory among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017. PMID: 28576906. doi:10.2215/CJN.12131116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。